Modafinil: A Review of Neurochemical Actions and Effects on Cognition
The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Abstract
Modafinil (2-[(Diphenylmethyl) sulfinyl] acetamide, Provigil) is an FDA-approved medication with wake-promoting properties. Pre-clinical studies of modafinil suggest a complex profile of neurochemical and behavioral effects, distinct from those of amphetamine. In addition, modafinil shows initial promise for a variety of off-label indications in psychiatry, including treatment-resistant depression, attention-deficit/hyperactivity disorder, and schizophrenia. Cognitive dysfunction may be a particularly important emerging treatment target for modafinil, across these and other neuropsychiatric disorders. We aimed to comprehensively review the empirical literature on neurochemical actions of modafinil, and effects on cognition in animal models, healthy adult humans, and clinical populations. We searched PubMed with the search term 'modafinil' and reviewed all English-language articles for neurochemical, neurophysiological, cognitive, or information-processing experimental measures. We additionally summarized the pharmacokinetic profile of modafinil and clinical efficacy in psychiatric patients. Modafinil exhibits robust effects on catecholamines, serotonin, glutamate, gamma amino-butyric acid, orexin, and histamine systems in the brain. Many of these effects may be secondary to catecholamine effects, with some selectivity for cortical over subcortical sites of action. In addition, modafinil (at well-tolerated doses) improves function in several cognitive domains, including workin…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, side effects of alpha agonists like guanfacine and clonidine include high prevalence of somnolence or sedating effects,168,169”
From Report of a Work Group on Sluggish Cognitive Tempo: Key Research Directions and a Consensus Change in Terminology to Cognitive Disengagement Syndrome (2023) · cites this paper as [168]
In the citing paper
“Modafinil, which is approved by the US Food and Drug Administration for the treatment of narcolepsy and its associated daytime sleepiness [59], is a logical candidate to address the hypoactive/sleepy aspects of CDS.”
Citations
Cites
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472 · cited 7×
“Importantly, modafinil also augments pupillary dilation parameters (Hou et al, 2005) in a manner consistent with LC phasic responses to task-relevant events (Beatty, 1982a, b; Richer and Beatty, 1987), suggesting the potential for LC/NE system effects in optimizing cognitive task performance, as described in the Aston…”
BackgroundMethodResultInfluentialNarcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095 · cited 3×
“m Fos in orexin neurons in perfornical area 150 mg/kg i.p. Immunohisto-chemistry Mice Chemelli et al, 1999 75 mg/kg i.p. Immunohisto-chemistry Rat Scammell et al, 2000 No binding to orexin-1 receptor IC50 410mM 125I-human-orexin B displacement Transfected Chinese Hamster Ovary cells Wieland et al,…”
BackgroundAston-Jones, G., & Bloom, F. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00876.1981 · Cited by 1,960 · cited 1×
“It appears also that when levels of tonic LC activity are minimal, such as during sleep, grooming, and eating, that phasic responses are also less robust (Aston-Jones and Bloom, 1981).”
BackgroundTask-evoked pupillary responses, processing load, and the structure of processing resources.
Beatty, J. (1982) · Psychological Bulletin · doi:10.1037/0033-2909.91.2.276 · Cited by 1,959 · cited 1×
“…modafinil also augments pupillary dilation parameters (Hou et al, 2005) in a manner consistent with LC phasic responses to task-relevant events (Beatty, 1982a, b; Richer and Beatty, 1987), suggesting the potential for LC/NE system effects in optimizing cognitive task performance, as described…”
The principal features and mechanisms of dopamine modulation in the prefrontal cortex
Seamans, J. K., & Yang, C. R. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.006 · Cited by 1,592 · cited 15×
“Inhibition of DA cell firing in VTA/SN; blocked by Sulpiride 10mM but not by Prazosin 20 mM Extracellular recording Rat brain slice Korotkova et al, 2006 Hyperpolarization of VTA neurons, blocked by Sulpiride 10mM 20–50mM Whole-cell patch clamp Isolated VTA neurons No effect on mesencephalic DA neuron activity 128 mg/…”
BackgroundInfluentialDissociation in prefrontal cortex of affective and attentional shifts
Dias, R., Robbins, T. W., & Roberts, A. C. (1996) · Nature · doi:10.1038/380069a0 · Cited by 1,527
D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory
Sawaguchi, T., & Goldman-Rakic, P. S. (1991) · Science · doi:10.1126/science.1825731 · Cited by 1,364
The role of histamine and the tuberomamillary nucleus in the nervous system
Haas, H., & Panula, P. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1034 · Cited by 929 · cited 5×
“Thalamic NET occupancy: 16, 44% 5, 8 mg/kg i.v. PET with [11C]MeNER Rhesus monkey Madras et al, 2006 NET binding IC50¼ 35.6mM [3H] NE Human Embryo Kidney No effect on pontine NE neuron activity 128 mg/kg i.p. Single-unit recording Rat (anesthetized) Akaoka et al, 1991 Extracellular NE: m in PFC, medial hypothalamus 12…”
BackgroundInfluentialDopaminergic Role in Stimulant-Induced Wakefulness
Wisor, J. P., Nishino, S., Sora, I., Uhl, G. H., Mignot, E., & Edgar, D. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01787.2001 · Cited by 769 · cited 7×
“…extracellular DA levels (measured by microdialysis) that are increased significantly in the rat prefrontal cortex (PFC) (de Saint Hilaire et al, 2001), and in the caudate nucleus of narcoleptic dogs (Wisor et al, 2001), although only minimally in the rat hypothalamus (de Saint Hilaire et al, 2001).”
BackgroundInfluentialThe role of locus coeruleus in the regulation of cognitive performance
Usher, M., Cohen, J. D., Servan-Schreiber, D., Rajkowski, J., & Aston-Jones, G. (1999) · Science · doi:10.1126/science.283.5401.549 · Cited by 715
Morón, J. A., Brockington, A., Wise, R. A., Rocha, B. A., & Hope, B. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00389.2002 · Cited by 681 · cited 1×
“There remains the possibility that the enhanced DA results from competition with NE for binding to the NET, which plays an important role in terminating DA action in the cortex (Carboni et al, 1990; Moron et al, 2002).”
BackgroundMathur, R. (2004) · Drug Screening Methods · doi:10.5005/jp/books/10243_6 · Cited by 665
Sawaguchi, T., & Goldman-Rakic, P. S. (1994) · Journal of Neurophysiology · doi:10.1152/jn.1994.71.2.515 · Cited by 649
Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task
Aston-Jones, G., Rajkowski, J., Kubiak, P., & Alexinsky, T. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-07-04467.1994 · Cited by 637
Arnsten, A. F. T., & Goldman-Rakic, P. S. (1985) · Science · doi:10.1126/science.2999977 · Cited by 549 · cited 2×
“In contrast, preferential activation of the presynaptic a2 autoreceptor impairs working memory, probably by reducing the terminal release of NA with reduced postsynaptic a2 receptor activation as a result (Arnsten and Goldman-Rakic, 1985).”
BackgroundTargeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction
Goldman-Rakic, P., Castner, S., Svensson, T., Siever, L., & Williams, G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1793-y · Cited by 544
Cognitive enhancing effects of modafinil in healthy volunteers
Turner, D. C., Robbins, T. W., Clark, L., Aron, A. R., Dowson, J., & Sahakian, B. J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1250-8 · Cited by 515 · cited 3×
“%) qd Performance at 30 mg/kg Ward et al, 2004 Cognitive battery Rat 0, 8, 32, 64 mg/kg i.p. m Accuracy, kRT and k premature responses on 3-choice visual attention task with long delay at 64 mg/kg only Visual discrimination performance; omission errors or measures of motivation or motor activity Morgan et al, 2007 5-C…”
BackgroundInfluentialCognition and control in schizophrenia: a computational model of dopamine and prefrontal function
Braver, T. S., Barch, D. M., & Cohen, J. D. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00116-x · Cited by 507
Hypothalamic Arousal Regions Are Activated during Modafinil-Induced Wakefulness
Scammell, T. E., Estabrooke, I. V., McCarthy, M. T., Chemelli, R. M., Yanagisawa, M., Miller, M. S., & Saper, C. B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08620.2000 · Cited by 485 · cited 18×
“Inhibition of DA cell firing in VTA/SN; blocked by Sulpiride 10mM but not by Prazosin 20 mM Extracellular recording Rat brain slice Korotkova et al, 2006 Hyperpolarization of VTA neurons, blocked by Sulpiride 10mM 20–50mM Whole-cell patch clamp Isolated VTA neurons No effect on mesencephalic DA neuron activity 128 mg/…”
BackgroundInfluentialModafinil for excessive sleepiness associated with shift work sleep disorder
Czeisler, C. A., Walsh, J. K., Roth, T., Hughes, R. J., Wright, K. P., Kingsbury, L., Arora, S., Schwartz, J. R. L., Niebler, G. E., & Dinges, D. F. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041292 · Cited by 413
Carboni, E., Tanda, G. L., Frau, R., & Chiara, G. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04599.x · Cited by 411 · cited 1×
“There remains the possibility that the enhanced DA results from competition with NE for binding to the NET, which plays an important role in terminating DA action in the cortex (Carboni et al, 1990; Moron et al, 2002).”
BackgroundMaintaining alertness and performance during sleep deprivation: modafinil versus caffeine
Wesensten, N., Belenky, G., Kautz, M. A., Thorne, D. R., Reichardt, R. M., & Balkin, T. J. (2002) · Psychopharmacology · doi:10.1007/s002130100916 · Cited by 404 · cited 1×
“…10-choice RT, 4-choice RT 10-, 4-choiceaccuracy; serial addition/ subtraction; modafinil (200, 400 mg) effects on RT comparable to caffeine 600 mg Wesensten et al, 2002 Cognitive battery Sleep-deprived healthy military recruits 41 300 mg p.o. for 3 days k Simple RT, m accuracy on short-term…”
BackgroundRandomized trial of modafinil for the treatment of pathological somnolence in narcolepsy
Fry, & US Modafinil in Narcolepsy Multicenter Study Group (1998) · Annals of Neurology · doi:10.1002/ana.410430115 · Cited by 396
A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence
Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., & O'Brien, C. P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300600 · Cited by 391
Smiley, J. F., Levey, A. I., Ciliax, B. J., & Goldman-Rakic, P. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5720 · Cited by 383
Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy
US Modafinil in Narcolepsy Multicenter Study Group (2000) · Neurology · doi:10.1212/wnl.54.5.1166 · Cited by 362
A Systematic Review of Modafinil: Potential Clinical Uses and Mechanisms of Action
Ballon, J. S., & Feifel, D. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0406 · Cited by 349 · cited 1×
“These studies are summarized below, and more comprehensively reviewed elsewhere (Ballon and Feifel, 2006).”
BackgroundUnder the curve: Critical issues for elucidating D1 receptor function in working memory
Williams, G. V., & Castner, S. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.028 · Cited by 326
Madras, B. K., Xie, Z., Lin, Z., Jassen, A., Panas, H., Lynch, L., Johnson, R., Livni, E., Spencer, T. J., Bonab, A. A., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106583 · Cited by 326 · cited 5×
“However, a recent positron emission tomography (PET) study of rhesus monkeys found significant binding of the DAT (using [11C]CFT) in the striatum (54% occupancy at 8 mg/kg) and norepinephrine (NE) transporter (NET) (using [11C]MeNER) in the thalamus (44% occupancy at 8 mg/kg) (Madras et al, 2006).”
BackgroundMethodInfluentialModafinil as Adjunct Therapy for Daytime Sleepiness in Obstructive Sleep Apnea
PACK, A. I., BLACK, J. E., SCHWARTZ, J. R. L., & MATHESON, J. K. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2103032 · Cited by 324
Modafinil Binds to the Dopamine Uptake Carrier Site with Low Affinity
Mignot, E., Nishino, S., Guilleminault, C., & Dement, W. C. (1994) · Sleep · doi:10.1093/sleep/17.5.436 · Cited by 318 · cited 4×
“…kidney Methylphenidate IC50¼ 35,600 nM IC50¼ 26.5 nM Inhibition of [3H] WIN 35428 binding Guinea pig striatum Cocaine IC50¼ 3190 nM IC50¼ 46.2 nM Mignot et al, 1994 Inhibition of DA neuron activity in mesencephalon Rat single-unit 128 mg/kg i.p. Amphetamine 5 mg/kg i.p. Firing rates…”
BackgroundInfluentialWESENSTEN, N. J., KILLGORE, W. D. S., & BALKIN, T. J. (2005) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2005.00468.x · Cited by 306 · cited 3×
“One study of adults with 85 h of sleep deprivation found single-dose modafinil 400 mg to reduce errors on the Wisconsin Card Sort Test (WCST) and interference on the Stroop (compared to placebo), and comparable to 600 mg caffeine and 20 mg amphetamine (Wesensten et al, 2005).”
BackgroundMethodInfluentialTurner, D. C., Clark, L., Dowson, J., Robbins, T. W., & Sahakian, B. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.008 · Cited by 301 · cited 4×
“%) qd Performance at 30 mg/kg Ward et al, 2004 Cognitive battery Rat 0, 8, 32, 64 mg/kg i.p. m Accuracy, kRT and k premature responses on 3-choice visual attention task with long delay at 64 mg/kg only Visual discrimination performance; omission errors or measures of motivation or motor activity Morgan et al, 2007 5-C…”
BackgroundInfluentialLin, J.-S., Hou, Y., & Jouvet, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14128 · Cited by 300 · cited 2×
“…1 mg/kg i.p. Greater labeling in anterior hypothalamus, SCN, PAG Greater labeling in caudate, accumbens, mediofrontal and temporal cortex, amygdala Lin et al, 1996 Methylphenidate 2.5 mg/kg i.p. Greater labeling in caudate, accumbens, mediofrontal and temporal cortex, amygdala c-Fos…”
BackgroundInfluentialBroughton, R. J., Fleming, J. A. E., George, C. F. P., Hill, J. D., Kryger, M. H., Moldofsky, H., Montplaisir, J. Y., Morehouse, R. L., Moscovitch, A., & Murphy, W. F. (1997) · Neurology · doi:10.1212/wnl.49.2.444 · Cited by 288
Williams, S. M., & Goldman-Rakic, P. S. (1993) · Cerebral Cortex · doi:10.1093/cercor/3.3.199 · Cited by 284 · cited 1×
“D1 receptors in the PFC are primarily found on the distal dendritic spines of pyramidal cells, often in conjunction with asymmetric, presumably glutamatergic synapses, and occasionally in triads which also include DA terminals (Smiley and Goldman-Rakic, 1993; Smiley et al, 1994; Williams and Goldman-Rakic, 1993).”
BackgroundThe computational role of dopamine D1 receptors in working memory
Durstewitz, D., & Seamans, J. K. (2002) · Neural Networks · doi:10.1016/s0893-6080(02)00049-7 · Cited by 267 · cited 1×
“This includes a depression of background PFC activity, which serves to make the self-sustained activity robust to noise (eg, distractors) (Durstewitz and Seamans, 2002).”
BackgroundModafinil Improves Cognition and Attentional Set Shifting in Patients with Chronic Schizophrenia
Turner, D. C., Clark, L., Pomarol-Clotet, E., McKenna, P., Robbins, T. W., & Sahakian, B. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300457 · Cited by 258 · cited 4×
“%) qd Performance at 30 mg/kg Ward et al, 2004 Cognitive battery Rat 0, 8, 32, 64 mg/kg i.p. m Accuracy, kRT and k premature responses on 3-choice visual attention task with long delay at 64 mg/kg only Visual discrimination performance; omission errors or measures of motivation or motor activity Morgan et al, 2007 5-C…”
BackgroundInfluentialPresynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits
Gao, W.-J., Krimer, L. S., & Goldman-Rakic, P. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.295 · Cited by 257
Clinical Pharmacokinetic Profile of Modafinil
Robertson, P., & Hellriegel, E. T. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342020-00002 · Cited by 256 · cited 3×
“Major pharmacokinetic parameters are independent of doses in the range of 200– 600 mg/day (Robertson and Hellriegel, 2003).”
BackgroundInfluentialChapter 23 Role of the locus coeruleus in emotional activation
Aston-Jones, G., Rajkowski, J., Kubiak, P., Valentino, R. J., & Shipley, M. T. (1996) · Progress in Brain Research · doi:10.1016/s0079-6123(08)61877-4 · Cited by 252
Loss of autoreceptor functions in mice lacking the dopamine transporter
Jones, S. R., Gainetdinov, R. R., Hu, X.-T., Cooper, D. C., Wightman, R. M., White, F. J., & Caron, M. G. (1999) · Nature Neuroscience · doi:10.1038/10204 · Cited by 249 · cited 1×
“Nevertheless, modafinil effects on wakefulness are abolished in DAT-knockout mice (Wisor et al, 2001), although it should be cautioned that D2 autoreceptor function also appears severely impaired in DAT-knockout mice (Jones et al, 1999).”
BackgroundBunney, B. S., & Aghajanian, G. K. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90087-4 · Cited by 247 · cited 1×
“Furthermore, a subset of medial PFC neurons are responsive to both neurotransmitters (Bunney and Aghajanian, 1976).”
BackgroundAn evaluation of the abuse potential of modafinil using methylphenidate as a reference
Jasinski, D. R. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400107 · Cited by 238 · cited 1×
“Modafinil also appears to have a relatively low potential for abuse, which may be a function of its pharmacodynamic profile and/or its physical properties, being insoluble in water and unstable at high temperatures, which minimizes its bioavailability upon smoking or intravenous use (Jasinski, 2000; Myrick et al, 2004…”
BackgroundMillan, M. J., Lejeune, F., & Gobert, A. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400202 · Cited by 231 · cited 1×
“Given that a receptors are found in high concentrations in the dorsal raphe nucleus and exert a tonic excitatory influence on raphe 5HT cell bodies (Millan et al, 2000), the modafinil effects on GABA may be mediated by adrenergic effects on 5HT activity.”
BackgroundAston-Jones, G., Rajkowski, J., & Kubiak, P. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00060-2 · Cited by 229
Marek, G. J., & Aghajanian, G. K. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00945-5 · Cited by 221 · cited 1×
“The effects on glutamate may interact with adrenergic mechanisms, as NE facilitates the synaptic release of glutamate onto medial PFC pyramidal cells, an effect blocked by prazosin but not by yohimbine (Marek and Aghajanian, 1999).”
BackgroundPerikaryal and synaptic localization ofα2A-adrenergic receptor-like immunoreactivity
Aoki, C., Go, C.-G., Venkatesan, C., & Kurose, H. (1994) · Brain Research · doi:10.1016/0006-8993(94)91782-5 · Cited by 221
Duteil, J., Rambert, F. A., Pessonnier, J., Hermant, J.-F., Gombert, R., & Assous, E. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90591-s · Cited by 220 · cited 6×
“…effects on activity in mice are modestly attenuated by the D1 receptor antagonist SCH 23390 (Simon et al, 1995), although not by haloperidol (Duteil et al, 1990); and the low-activity catechol-O-methyl transferase genotype is associated with greater clinical response to modafinil among…”
BackgroundInfluentialD1Receptor in Interneurons of Macaque Prefrontal Cortex: Distribution and Subcellular Localization
Muly, E. C., Szigeti, K., & Goldman-Rakic, P. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-24-10553.1998 · Cited by 217
Smiley, J. F., & Goldman-Rakic, P. S. (1993) · Cerebral Cortex · doi:10.1093/cercor/3.3.223 · Cited by 211 · cited 1×
“D1 receptors in the PFC are primarily found on the distal dendritic spines of pyramidal cells, often in conjunction with asymmetric, presumably glutamatergic synapses, and occasionally in triads which also include DA terminals (Smiley and Goldman-Rakic, 1993; Smiley et al, 1994; Williams and Goldman-Rakic, 1993).”
BackgroundHieble, J. P., Bondinell, W., & Ruffolo, R. R. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00018a001 · Cited by 209 · cited 1×
“In addition, pre-treatment with a antagonists prazosin (which acts primarily at a1, but also has a lower affinity for a2 receptors (Hieble et al, 1995)) or phenoxybenzamine diminishes modafinil-induced increases in arousal (Lin et al, 1992) and activity in rats and monkeys (Duteil et al, 1990;…”
BackgroundFava, M., Thase, M. E., & DeBattista, C. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0112 · Cited by 207
Lin, J. S., Roussel, B., Akaoka, H., Fort, P., Debilly, G., & Jouvet, M. (1992) · Brain Research · doi:10.1016/0006-8993(92)91713-o · Cited by 203 · cited 5×
“Modest attenuation of modafinil-induced arousal and activity has also been observed after pretreatment with the b-blocker propranolol (Duteil et al, 1990; Lin et al, 1992).”
BackgroundInfluentialModafinil in treatment of fatigue in multiple sclerosis
Zifko, U. A., Rupp, M., Schwarz, S., Zipko, H. T., & Maida, E. M. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0765-6 · Cited by 200
Devoto, P., Flore, G., Pani, L., & Gessa, G. L. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000904 · Cited by 196 · cited 1×
“…the medial PFC (as well as occipital cortex) upon LC activation by either direct electrical stimulation or local infusion of a2 receptor antagonists, whereas both DA and NE are reduced in both cortical areas by local or systemic clonidine (Devoto et al, 2001, 2003, 2004a, b; Kawahara et al, 2001).”
BackgroundHarsh, J. R., Hayduk, R., Rosenberg, R., Wesnes, K. A., Walsh, J. K., Arora, S., Niebler, G. E., & Roth, T. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x100050 · Cited by 195 · cited 1×
“…composite of RT on WM and recog memory tasks (250 mg and combined dose groups) Non-sig m score composite of accuracy on choice RT and digit vigilance Harsh et al, 2006 Arithmetic (Pauli Test) and visual/auditory divided attention Narcolepsy patients medicationfree 15 400 mg p.o. vs placebo for 3…”
MethodPIGEAU, R., NAITOH, P., BUGUET, A., McCANN, C., BARANSKI, J., TAYLOR, M., THOMPSON, M., & MACK, I. (1995) · Journal of Sleep Research · doi:10.1111/j.1365-2869.1995.tb00172.x · Cited by 191 · cited 2×
“…battery Sleep-deprived healthy military recruits 41 300 mg p.o. for 3 days k Simple RT, m accuracy on short-term memory, logical reasoning NA Pigeau et al, 1995 AX-CPT, coding task (similar to digit symbol) Sleep-deprived healthy ER physicians 25 200 mg p.o. double-blind, withinsubjects…”
MethodTAYLOR, F. B., & RUSSO, J. (2000) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2000.10.311 · Cited by 180 · cited 4×
“A randomized, double-blind, placebo-controlled three-phase crossover study of 22 adults with ADHD found improvements in DSM-IV ADHD Behavior Checklist for Adults compare to placebo, for both modafinil (2 weeks after titration to mean 207 mg/day) and amphetamine (Taylor and Russo, 2000).”
MethodInfluentialEagle, D. M., Tufft, M. R. A., Goodchild, H. L., & Robbins, T. W. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0701-7 · Cited by 176 · cited 4×
“…effect on cis-flupenthixol-related m GoRT k SSRT in slow rats but m SSRT in fast rats; k go-trial RT in all rats; blocked cisflupenthixol-related m GoRT Eagle et al, 2007 Executive function and simple reaction time Humans 400 mg p.o. Amphetamine 20 mg p.o. k Simple RT, m WCST; no effect on verbal…”
BackgroundInfluentialEffects of modafinil on working memory processes in humans
M�ller, U., Steffenhagen, N., Regenthal, R., & Bublak, P. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1926-3 · Cited by 170 · cited 2×
“…improvements in working memory, such as on maintenance and manipulation and delayed matching tasks, without a speed-accuracy trade-off, or effects on attention tasks (Muller et al, 2004); and on vigilance, but not perceptual, arithmetic, or reasoning performance (Baranski et al, 2004).”
BackgroundMethodEdgar, D. M., & Seidel, W. F. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37050-8 · Cited by 168 · cited 3×
“…(Engber et al, 1998b; Lin et al, 1996); it does not produce behavioral stereotypies (Duteil et al, 1990; Simon et al, 1995) or rebound hypersomnia (Edgar and Seidel, 1997; Lin et al, 2000; Touret et al, 1995; Willie et al, 2005; Wisor et al, 2006); it does not significantly alter behavior in the…”
BackgroundInfluentialArnsten, A. F. T., & Contant, T. A. (1992) · Psychopharmacology · doi:10.1007/bf02245302 · Cited by 168 · cited 1×
“The role of post-synaptic a2 receptor-mediated transient increases in PFC delay-related activity (Li et al, 1999; Sawaguchi, 1998), and associated mitigation of interference in task performance (Arnsten and Contant, 1992), suggest a point of convergence of the Arnsten model of adrenergic function with the Aston-Jones…”
MethodPhasic Not Tonic Pupillary Responses Vary With Auditory Vigilance Performance
Beatty, J. (1982) · Psychophysiology · doi:10.1111/j.1469-8986.1982.tb02540.x · Cited by 163 · cited 1×
“…modafinil also augments pupillary dilation parameters (Hou et al, 2005) in a manner consistent with LC phasic responses to task-relevant events (Beatty, 1982a, b; Richer and Beatty, 1987), suggesting the potential for LC/NE system effects in optimizing cognitive task performance, as described…”
Li, B. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00070-6 · Cited by 162
Modafinil: A Double-Blind Multicentric Study
Billiard, M., Besset, A., Montplaisir, J., Laffont, F., Goldenberg, F., Weill, J. S., & Lubin, S. (1994) · Sleep · doi:10.1093/sleep/17.suppl_8.s107 · Cited by 162 · cited 1×
“However, modafinil lacks the capacity to reduce cataplexy in dogs or humans with narcolepsy (Billiard et al, 1994; Shelton et al, 1995), a feature which is similar to other DAT inhibitors, and in contrast to a1B agonists and NET inhibitors (Mignot et al, 1993; Nishino et al, 1993).”
ResultThe functional anatomy of verbal initiation and suppression using the Hayling Test
Nathaniel-James, D. A., Fletcher, P. C., & Frith, C. (1997) · Neuropsychologia · doi:10.1016/s0028-3932(96)00104-2 · Cited by 161 · cited 1×
“…(compared to placebo) on the WCST and the Hayling Sentence Completion Test (Walsh et al, 2004), which requires cognitive control and is associated with activation of dorsolateral PFC (Nathaniel-James and Frith, 2002) and anterior cingulate cortex (Nathaniel-James et al, 1997) measured by fMRI.”
BackgroundGreenhill, L. L., Biederman, J., Boellner, S. W., Rugino, T. A., Sangal, R. B., Earl, C. Q., JIANG, J. G., & Swanson, J. M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000205709.63571.c9 · Cited by 160 · cited 1×
“…flexible dose 85–425 mg p.o. qd (mean 361 mg) for 2–56 days (mean 31.5 d) m TOVA ADHD score at final visit, incl inattention subscore TOVA commission errors Greenhill et al, 2006 M o d a fin il n e u ro c h e m istry a n d c o g n itio n M J M inzenb erg and C S C arter 1 4 9 0 N euro p sycho…”
BackgroundInfluentialWong, Y. N., Simcoe, D., Hartman, L. N., Laughton, W. B., King, S. P., McCormick, G. C., & Grebow, P. E. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922007534 · Cited by 158 · cited 5×
“The elimination half-life is approximately 12–15 h (Wong et al, 1999a), and single daily dosing is adequate and common in clinical practice.”
BackgroundInfluentialTrace Amine-Associated Receptor 1 Is a Modulator of the Dopamine Transporter
Xie, Z., & Miller, G. M. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.117382 · Cited by 157 · cited 1×
“…interactions between the TA1 receptor and both DA neuron activity in rats (Geracitano et al, 2004) and DAT activity in primates (Miller et al, 2005; Xie and Miller, 2007; Xie et al, Modafinil neurochemistry and cognition MJ Minzenberg and CS Carter 1478 Neuropsychopharmacology Table 1 Effects of…”
Backgroundde Saint-Hilaire, Z., Orosco, M., Rouch, C., Blanc, G., & Nicolaidis, S. (2001) · NeuroReport · doi:10.1097/00001756-200111160-00032 · Cited by 156 · cited 6×
“…extracellular DA levels (measured by microdialysis) that are increased significantly in the rat prefrontal cortex (PFC) (de Saint Hilaire et al, 2001), and in the caudate nucleus of narcoleptic dogs (Wisor et al, 2001), although only minimally in the rat hypothalamus (de Saint Hilaire et al, 2001).”
BackgroundInfluentialFerraro, L. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00085-2 · Cited by 153 · cited 5×
“…GABA: k in mPOA, post hypothalamus; effects neg correlated with modafinil effects on glutamate 30–300 mg/kg i.p. Intracranial microdialysis Rat Ferraro et al, 1996, 1999 Extracellular GABA: kin striatum, pallidum, SN; no effects @ 30 mg/kg 30–300 mg/kg i.p. Intracranial microdialysis Rat…”
BackgroundInfluentialEvaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil
Gold, L. H., & Balster, R. L. (1996) · Psychopharmacology · doi:10.1007/bf02247379 · Cited by 153 · cited 2×
“In a rodent drug discrimination paradigm, modafinil partially generalizes to a cocaine-like stimulus (Gold and Balster, 1996); in addition, modafinil effects on activity in mice are modestly attenuated by the D1 receptor antagonist SCH 23390 (Simon et al, 1995), although not by haloperidol (Duteil…”
BackgroundDevoto, P., Flore, G., Saba, P., Fà, M., & Gessa, G. L. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02866.x · Cited by 150 · cited 1×
“However, recent evidence suggests that the DA and NE increases in the medial PFC upon LC stimulation are somewhat independent of each other (Devoto et al, 2005).”
BackgroundMitler, M. M., Harsh, J., Hirshkowitz, M., & Guilleminault, C. (2000) · Sleep Medicine · doi:10.1016/s1389-9457(00)00031-9 · Cited by 147
Roth, T. G., White, D. P., Schmidt-Nowara, W. W., Wesnes, K. A., Niebler, G. E., Arora, S., & Black, J. E. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.05.013 · Cited by 146
Hou, R. H., Freeman, C., Langley, R. W., Szabadi, E., & Bradshaw, C. M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0013-8 · Cited by 145 · cited 1×
“Importantly, modafinil also augments pupillary dilation parameters (Hou et al, 2005) in a manner consistent with LC phasic responses to task-relevant events (Beatty, 1982a, b; Richer and Beatty, 1987), suggesting the potential for LC/NE system effects in optimizing cognitive task performance, as…”
ResultA Prospective Trial of Modafinil as an Adjunctive Treatment of Major Depression
DeBattista, C., Lembke, A., Solvason, H. B., Ghebremichael, R., & Poirier, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000104910.75206.b9 · Cited by 144 · cited 3×
“%) qd Performance at 30 mg/kg Ward et al, 2004 Cognitive battery Rat 0, 8, 32, 64 mg/kg i.p. m Accuracy, kRT and k premature responses on 3-choice visual attention task with long delay at 64 mg/kg only Visual discrimination performance; omission errors or measures of motivation or motor activity Morgan et al, 2007 5-C…”
BackgroundInfluentialCentral histaminergic system and cognition
Passani, M. B., Bacciottini, L., Mannaioni, P. F., & Blandina, P. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00053-6 · Cited by 143 · cited 1×
“Nevertheless, a role for HA in a range of learning and memory paradigms is now established, with apparent opposing effects of H1 and H3 receptor activation, both of which may exert cognitive effects in interaction with cortical acetylcholine (Passani et al, 2000).”
BackgroundDopaminergic—adrenergic interactions in the wake promoting mechanism of modafinil
Wisor, J. P., & Eriksson, K. S. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.02.003 · Cited by 143 · cited 8×
“Interestingly, pre-treatment with the NE-selective neurotoxin DSP-4 (which leaves DA neurons intact) does not affect modafinil-induced wakefulness, yet in these NE-lesioned mice both terazosin and the DA autoreceptor agonist quinpirole blunt the modafinil effects (Wisor and Eriksson, 2005).”
BackgroundInfluentialAdrenergic targets for the treatment of cognitive deficits in schizophrenia
Arnsten, A. F. T. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1724-3 · Cited by 141 · cited 2×
“Importantly, there does not appear to be an inverted-Ushaped curve relating working memory performance to a2 agonist dose (Arnsten, 2004), and these effects probably occur at post-synaptic sites (Arnsten and Goldman-Rakic, 1985; Cai et al, 1993), where a2 receptors are found on asymmetric (probably excitatory) synapse…”
BackgroundFerraro, L., Antonelli, T., O'Connor, W. T., Tanganelli, S., Rambert, F. A., & Fuxé, K. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00353-3 · Cited by 140 · cited 9×
“…Firing rates 85–105% Firing rates 13% Extracellular accumbens DA by microdialysis Rat 100, 300 mg/kg i.p. Amphetamine 1 mg/kg i.p. Peak m 61% Peak m 925% Ferraro et al, 1997b Extracellular accumbens GABA by microdialysis Amphetamine 1 mg/kg i.p. Nadir k24% 0% change Catechol oxidation by in…”
BackgroundInfluentialModafinil: Preclinical, Clinical, and Post-Marketing Surveillance—A Review of Abuse Liability Issues
Myrick, H., Malcolm, R. J., Taylor, B. R., & LaRowe, S. D. (2004) · Annals of Clinical Psychiatry · doi:10.1080/10401230490453743 · Cited by 138
Gallopin, T., Luppi, P., Rambert, F. A., Frydman, A. M., & Fort, P. (2004) · SLEEP · doi:10.1093/sleep/27.1.19 · Cited by 138 · cited 3×
“…of VLPO neuron activity; effect blocked by nisoxetine; no effect of modafinil alone 200mM pre-treatment Extracellular recording Rat brain slice Gallopin et al, 2004 Extracellular GABA: no modafinil effect in cortex in prazosin pre-treated rats 30 mg/kg i.p. Intracranial microdialysis Rat…”
BackgroundInfluentialCognitive effects of modafinil in student volunteers may depend on IQ
Randall, D. C., Shneerson, J. M., & File, S. E. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.07.019 · Cited by 135 · cited 5×
“A different research group has found a single dose of modafinil 100 mg to improve performance on digit span and a sustained attention task (Randall et al, 2005b), yet failed to find significant improvement on a range of other cognitive tests with single doses of 100 or 200 mg modafinil in this and…”
BackgroundInfluentialBiederman, J., Swanson, J. M., Wigal, S. B., Kratochvil, C. J., Boellner, S. W., Earl, C. Q., Jiang, J., & Greenhill, L. L. (2005) · PEDIATRICS · doi:10.1542/peds.2005-0617 · Cited by 132
Lewis, D. A., & Morrison, J. H. (1989) · The Journal of Comparative Neurology · doi:10.1002/cne.902820302 · Cited by 132 · cited 1×
“For instance, DA and NE share a similar pattern of innervation of the medial PFC in the nonhuman primate (Lewis and Morrison, 1989).”
BackgroundModafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy
MacDonald, J. R., Hill, J. D., & Tarnopolsky, M. A. (2002) · Neurology · doi:10.1212/01.wnl.0000037481.08283.51 · Cited by 131
Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome
Hirshkowitz, M., Black, J. E., Wesnes, K. A., Niebler, G. E., Arora, S., & Roth, T. G. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.06.007 · Cited by 131
Tassin, J., Bockaert, J., Blanc, G. ́., Stinus, L., Thierry, A. M., Lavielle, S., Pre´mont, J., & Glowinski, J. (1978) · Brain Research · doi:10.1016/0006-8993(78)90698-4 · Cited by 128 · cited 1×
“Despite the common conception that DAT is strictly localized to the striatum (and absent in the frontal cortex), rodents exhibit significant levels of DAT binding in the anterior cingulate, prelimbic, and rostral areas of frontal cortex (Sesack et al, 1998; Tassin et al, 1978).”
BackgroundPrimate Trace Amine Receptor 1 Modulation by the Dopamine Transporter
Miller, G. M., Verrico, C. D., Jassen, A. K., Konar, M., Yang, H. S., Panas, H. N., Bahn, M. E., Johnson, R., & Madras, B. K. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084459 · Cited by 127 · cited 1×
“…for modulatory interactions between the TA1 receptor and both DA neuron activity in rats (Geracitano et al, 2004) and DAT activity in primates (Miller et al, 2005; Xie and Miller, 2007; Xie et al, Modafinil neurochemistry and cognition MJ Minzenberg and CS…”
BackgroundModafinil Improves Alertness, Vigilance, and Executive Function During Simulated Night Shifts
Walsh, J. K., Randazzo, A. C., Stone, K., & Schweitzer, P. K. (2004) · SLEEP · doi:10.1093/sleep/27.3.434 · Cited by 125 · cited 3×
“One study of healthy adults undergoing simulated night-shift work found a 4-day regimen of modafinil 200 mg to reduce errors (compared to placebo) on the WCST and the Hayling Sentence Completion Test (Walsh et al, 2004), which requires cognitive control and is associated with activation of dorsolateral PFC (Nathaniel-…”
BackgroundMethodNathaniel-James, D. A., & Frith, C. D. (2002) · NeuroImage · doi:10.1006/nimg.2002.1167 · Cited by 125 · cited 2×
“One study of healthy adults undergoing simulated night-shift work found a 4-day regimen of modafinil 200 mg to reduce errors (compared to placebo) on the WCST and the Hayling Sentence Completion Test (Walsh et al, 2004), which requires cognitive control and is associated with activation of dorsolateral PFC (Nathaniel-…”
BackgroundEffects of modafinil on cognitive and meta‐cognitive performance
Baranski, J. V., Pigeau, R., Dinich, P., & Jacobs, I. A. (2004) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.596 · Cited by 123 · cited 2×
“…mg/kg p.o. double-blind, placebo-controlled within-subjects Serial RT, logical reasoning, 1-Back Addition, line discrimination, confidence judgments Baranski et al, 2004 Somatosensory evoked potentials (median nerve stimulation) Healthy adults 6 100 mg p.o. m 500–700 Hz oscillation (12–18 ms…”
BackgroundCai, J. X., Ma, Y.-Y., Xu, L., & Hu, X.-T. (1993) · Brain Research · doi:10.1016/0006-8993(93)91034-p · Cited by 122
Modafinil increases histamine release in the anterior hypothalamus of rats
Ishizuka, T., Sakamoto, Y., Sakurai, T., & Yamatodani, A. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00006-5 · Cited by 122 · cited 16×
“Inhibition of DA cell firing in VTA/SN; blocked by Sulpiride 10mM but not by Prazosin 20 mM Extracellular recording Rat brain slice Korotkova et al, 2006 Hyperpolarization of VTA neurons, blocked by Sulpiride 10mM 20–50mM Whole-cell patch clamp Isolated VTA neurons No effect on mesencephalic DA neuron activity 128 mg/…”
BackgroundInfluentialWong, Y. N., King, S. P., Simcoe, D. K., Gorman, S., Laughton, W. B., McCormick, G. C., & Grebow, P. E. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/009127009903900312 · Cited by 120 · cited 5×
“The elimination half-life is approximately 12–15 h (Wong et al, 1999a), and single daily dosing is adequate and common in clinical practice.”
BackgroundInfluentialXie, Z., Westmoreland, S. V., Bahn, M. E., Chen, G., Yang, H. S., Vallender, E. J., Yao, W., Madras, B. K., & Miller, G. M. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116863 · Cited by 120
Modafinil affects mood, but not cognitive function, in healthy young volunteers
Randall, D. C., Shneerson, J. M., Plaha, K. K., & File, S. E. (2002) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.456 · Cited by 119 · cited 2×
“However, this group has studied university students who appear to have a high IQ (average of 115 in one study), with likely general ceiling effects on performance (Randall et al, 2003, 2005a).”
BackgroundFerraro, L., Antonelli, T., O'Connor, W. T., Tanganelli, S., Rambert, F. A., & Fuxé, K. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00629-6 · Cited by 119 · cited 5×
“It increases extracellular glutamate in the thalamus, and at higher doses, in the hippocampus (Ferraro et al, 1997a) and striatum (Ferraro et al, 1998).”
BackgroundInfluentialIn Vitro Inhibition and Induction of Human Hepatic Cytochrome P450 Enzymes by Modafinil
Robertson, P., DeCory, H. H., Madan, A., & Parkinson, A. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15146-x · Cited by 116 · cited 2×
“These effects are in general advantageous for cognitive processes.”
BackgroundEffects of Modafinil in Children With Attention-Deficit/Hyperactivity Disorder: An Open-Label Study
Rugino, T. A., & COPLEY, T. C. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00018 · Cited by 115 · cited 2×
“6 weeks (Rugino and Copley, 2001); a follow-up study of 22 children with ADHD, using a randomized, placebo-controlled design with an average dose of 264 mg/ day for an average of 6 weeks (Rugino and Samsock, 2003); and in a recent, much larger study of childhood ADHD, which included 100 completers in the modafiniltrea…”
BackgroundMethodMignot, E. J.-M., Renaud, A., Nishino, S., Arrigoni, J., Guilleminault, C., & Dement, W. C. (1993) · Psychopharmacology · doi:10.1007/bf02244337 · Cited by 115 · cited 1×
“However, modafinil lacks the capacity to reduce cataplexy in dogs or humans with narcolepsy (Billiard et al, 1994; Shelton et al, 1995), a feature which is similar to other DAT inhibitors, and in contrast to a1B agonists and NET inhibitors (Mignot et al, 1993; Nishino et al, 1993).”
ResultEngber, T. M., Koury, E. J., Dennis, S. A., Miller, M. S., Contreras, P. C., & Bhat, R. V. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00962-2 · Cited by 115 · cited 4×
“…blood flow (Florence et al, 2000), and different patterns of metabolic activation (Engber et al, 1998a) and c-Fos induction compared to amphetamine (Engber et al, 1998b; Lin et al, 1996); it does not produce behavioral stereotypies (Duteil et al, 1990; Simon et al, 1995) or rebound hypersomnia…”
BackgroundMethodInfluentialDopamine decreases the calcium-activated afterhyperpolarization in hippocampal CA1 pyramidal cells
Malenka, R. C., & Nicoll, R. A. (1986) · Brain Research · doi:10.1016/0006-8993(86)90773-0 · Cited by 111 · cited 1×
“DA has an affinity for cloned mouse a1B receptors, which is on the same order of magnitude as NE (Zhang et al, 2004), and DA can activate adrenergic receptors in various brain regions (Cornil et al, 2002; Crochet and Sakai, 2003; Malenka and Nicoll, 1986).”
BackgroundThe antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus
Ferraro, L., Antonelli, T., O'Connor, W. T., Tanganelli, S., Rambert, F. A., & Fuxé, K. (1997) · Neuroreport · doi:10.1097/00001756-199709080-00016 · Cited by 111 · cited 8×
“…Firing rates 85–105% Firing rates 13% Extracellular accumbens DA by microdialysis Rat 100, 300 mg/kg i.p. Amphetamine 1 mg/kg i.p. Peak m 61% Peak m 925% Ferraro et al, 1997b Extracellular accumbens GABA by microdialysis Amphetamine 1 mg/kg i.p. Nadir k24% 0% change Catechol oxidation by in…”
BackgroundInfluentialDopamine Activates Noradrenergic Receptors in the Preoptic Area
Cornil, C. A., Balthazart, J., Motté, P., Massotte, L., & Seutin, V. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09320.2002 · Cited by 111 · cited 1×
“DA has an affinity for cloned mouse a1B receptors, which is on the same order of magnitude as NE (Zhang et al, 2004), and DA can activate adrenergic receptors in various brain regions (Cornil et al, 2002; Crochet and Sakai, 2003; Malenka and Nicoll, 1986).”
BackgroundFerraro, L., Tanganelli, S., O'Connor, W. T., Antonelli, T., Rambert, F. A., & Fuxé, K. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13212-2 · Cited by 107 · cited 17×
“Inhibition of DA cell firing in VTA/SN; blocked by Sulpiride 10mM but not by Prazosin 20 mM Extracellular recording Rat brain slice Korotkova et al, 2006 Hyperpolarization of VTA neurons, blocked by Sulpiride 10mM 20–50mM Whole-cell patch clamp Isolated VTA neurons No effect on mesencephalic DA neuron activity 128 mg/…”
BackgroundInfluentialModafinil as Adjunct Therapy for Daytime Sleepiness in Obstructive Sleep Apnea
Schwartz, J. R. L., Hirshkowitz, M., Erman, M. K., & Schmidt-Nowara, W. (2003) · Chest · doi:10.1378/chest.124.6.2192 · Cited by 107
Acetylcholine, Histamine, and Cognition: Two Sides of the Same Coin
Blandina, P., Efoudebe, M., Cenni, G., Mannaioni, P. F., & Passani, M. B. (2004) · Learning & Memory · doi:10.1101/lm.68004 · Cited by 106 · cited 1×
“Interestingly, despite the close interaction between central HA and acetylcholine systems (Blandina et al, 2004), modafinil does not appear to affect extracellular acetylcholine in the cortex (Tanganelli et al, 1992) and does not reverse the scopolamine-induced increase in omission errors on the…”
BackgroundGill, M., Haerich, P., Westcott, K., Godenick, K. L., & Tucker, J. A. (2006) · Academic Emergency Medicine · doi:10.1197/j.aem.2005.08.013 · Cited by 105 · cited 2×
“A double-blind, placebo-controlled study of emergency department physicians participating after an overnight work shift found single-dose modafinil 200 mg to improve accuracy (relative to placebo) on both AX and AY conditions of the AX-CPT task (Gill et al, 2006).”
BackgroundNon-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice
Simon, P. Y. R., Hémet, C., Ramassamy, C., & Costentin, J. (1995) · European Neuropsychopharmacology · doi:10.1016/0924-977x(95)00041-m · Cited by 104
Chattopadhyay, N., Singh, D. P., Heese, O., Godbole, M. M., Shinohara, T., Black, P. M., & Brown, E. M. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000701)61:1<52::aid-jnr6>3.0.co;2-t · Cited by 103
Swanson, J. M., Greenhill, L. L., López, F. A., Sedillo, A., Earl, C. Q., Jiang, J. G., & Biederman, J. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0120 · Cited by 103
Impact of Modafinil on Prefrontal Executive Function in Schizophrenia
Hunter, M. D., Ganesan, V., Wilkinson, I. D., & Spence, S. A. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.12.2184 · Cited by 103 · cited 1×
“…Bilateral DLPFC (BA 46) activation; left BA 46 correlated r¼ 0.65 with coefficient of variation; neg correlated with baseline verbal fluency NA Hunter et al, 2006 Cognitive battery Schizophrenia patients 13 vs 11 200 mg p.o. qd vs placebo for 8 weeks No significant effects on cognition…”
BackgroundInfluentialCellular and subcellular localization of the dopamine transporter in rat cortex
Sesack, S. R., Hawrylak, V. A., Guido, M. A., & Levey, A. I. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60720-6 · Cited by 101 · cited 1×
“Despite the common conception that DAT is strictly localized to the striatum (and absent in the frontal cortex), rodents exhibit significant levels of DAT binding in the anterior cingulate, prelimbic, and rostral areas of frontal cortex (Sesack et al, 1998; Tassin et al, 1978).”
BackgroundModafinil modulates anterior cingulate function in chronic schizophrenia
Spence, S. A., Green, R. D., Wilkinson, I. D., & Hunter, M. D. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.187.1.55 · Cited by 99 · cited 1×
“…DLPFC, IPL, right posterior parietal and ACC in 2- vs 0-Back Accuracy on 2-Back at chance for both modafinil and placebo conditions; no effect on 0-Back Spence et al, 2005 fMRI with task demand of aperiodic motor variation (SAINT) Schizophrenia patients 12 100 mg p.o. vs placebo; double-blind…”
BackgroundHermant, J.-F., Rambert, F. A., & Duteil, J. (1991) · Psychopharmacology · doi:10.1007/bf02244069 · Cited by 99 · cited 3×
“…affinity for a2 receptors (Hieble et al, 1995)) or phenoxybenzamine diminishes modafinil-induced increases in arousal (Lin et al, 1992) and activity in rats and monkeys (Duteil et al, 1990; Hermant et al, 1991), as does terazosin pre-treatment or a1B receptor knockouts in mice (Stone et al, 2002a).”
BackgroundInfluentialEngber, T. M., Dennis, S. A., Jones, B. E., Miller, M. S., & Contreras, P. C. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00015-3 · Cited by 99 · cited 4×
“…blood flow (Florence et al, 2000), and different patterns of metabolic activation (Engber et al, 1998a) and c-Fos induction compared to amphetamine (Engber et al, 1998b; Lin et al, 1996); it does not produce behavioral stereotypies (Duteil et al, 1990; Simon et al, 1995) or rebound hypersomnia…”
BackgroundMethodInfluentialDoes Modafinil Enhance Cognitive Performance in Young Volunteers Who Are Not Sleep-Deprived?
Randall, D. C., Viswanath, A., Bharania, P., Elsabagh, S., Hartley, D. E., Shneerson, J. M., & File, S. E. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000155816.21467.25 · Cited by 97 · cited 5×
“A different research group has found a single dose of modafinil 100 mg to improve performance on digit span and a sustained attention task (Randall et al, 2005b), yet failed to find significant improvement on a range of other cognitive tests with single doses of 100 or 200 mg modafinil in this and…”
BackgroundInfluentialMurillo‐Rodríguez, E., Haro, R., Palomero‐Rivero, M., Millán‐Aldaco, D., & Drucker-Colı́n, R. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.10.016 · Cited by 94 · cited 1×
“…Rat Ferraro et al, 1997b Extracellular DA: m in nucleus accumbens, blocked partly by anandamide 10 mg/5ml i.c.v. Intracranial microdialysis Rat Murillo-Rodriguez et al, 2007 k cortical GABA by modafinil abolished in 6-OHDAlesioned animals 30 mg/kg s.c. for 7 d Intracranial microdialysis…”
BackgroundDinges, D. F., Arora, S., Darwish, M., & Niebler, G. E. (2005) · Current Medical Research and Opinion · doi:10.1185/030079906x80378 · Cited by 94 · cited 2×
“The R-enantiomer (armodafinil) appears to reach higher plasma concentrations than the racemic form between 6–14 h after administration, with an associated longer duration of wake-promoting activity in healthy adults (Dinges et al, 2006).”
Backgroundネコ脳のアンフェタミン,メチルフェニデート,モダフィニルの覚醒作用における標的ニューロンのc‐fos免疫組織化学による検索
J‐S, L., Yulong, H., & Jouvet, M. (1996) · Cited by 93
Devoto, P., Flore, G., Pira, L., Longu, G., & Gessa, G. L. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.01.018 · Cited by 91 · cited 1×
“…the medial PFC (as well as occipital cortex) upon LC activation by either direct electrical stimulation or local infusion of a2 receptor antagonists, whereas both DA and NE are reduced in both cortical areas by local or systemic clonidine (Devoto et al, 2001, 2003, 2004a, b; Kawahara et al, 2001).”
BackgroundFerraro, L., Fuxé, K., Tanganelli, S., Fernández, M., Rambert, F. A., & Antonelli, T. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00019-8 · Cited by 91 · cited 4×
“Modafinil causes elevations in extracellular 5HT that are significant and dose-dependent in the frontal cortex, central nucleus of the amygdala, and dorsal raphe nucleus, but minimal in the hypothalamus (de Saint Hilaire et al, 2001; Ferraro et al, 2000, 2002).”
BackgroundResultInfluentialShelton, J., Nishino, S., Vaught, J., Dement, W. C., & Mignot, E. J.-M. (1995) · SLEEP · doi:10.1093/sleep/18.10.817 · Cited by 91 · cited 1×
“However, modafinil lacks the capacity to reduce cataplexy in dogs or humans with narcolepsy (Billiard et al, 1994; Shelton et al, 1995), a feature which is similar to other DAT inhibitors, and in contrast to a1B agonists and NET inhibitors (Mignot et al, 1993; Nishino et al, 1993).”
ResultDevoto, P., Flore, G., Pira, L., Longu, G., & Gessa, G. L. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02239.x · Cited by 90 · cited 1×
“…the medial PFC (as well as occipital cortex) upon LC activation by either direct electrical stimulation or local infusion of a2 receptor antagonists, whereas both DA and NE are reduced in both cortical areas by local or systemic clonidine (Devoto et al, 2001, 2003, 2004a, b; Kawahara et al, 2001).”
BackgroundContrasting Effects of Response Uncertainty on the Task‐Evoked Pupillary Response and Reaction Time
Richer, F., & Beatty, J. (1987) · Psychophysiology · doi:10.1111/j.1469-8986.1987.tb00291.x · Cited by 89 · cited 2×
“Importantly, modafinil also augments pupillary dilation parameters (Hou et al, 2005) in a manner consistent with LC phasic responses to task-relevant events (Beatty, 1982a, b; Richer and Beatty, 1987), suggesting the potential for LC/NE system effects in optimizing cognitive task performance, as described in the Aston…”
MethodResultModafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates
Willie, J. T., Renthal, W. R., Chemelli, R. M., Miller, M. S., Scammell, T. E., Yanagisawa, M., & Sinton, C. M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.10.005 · Cited by 89 · cited 4×
“…and m effect of modafinil on waking EEG, in orexin-null mice 10, 100 mg/kg i.p. Immunohisto-chemistry; EEG, time awake/asleep Orexin-null mice Willie et al, 2005 No change in effects on extracellular DA in striatum, or wake-promoting activity, in orexin-2 receptor-null narcoleptic dogs 5…”
BackgroundInfluentialSevy, S. M., & Rosenthal, M. H. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0705 · Cited by 85 · cited 1×
“…patients 13 vs 11 200 mg p.o. qd vs placebo for 8 weeks No significant effects on cognition between groups CPT-IP, ODR, DMS, RAVLT, letter-number span Sevy et al, 2005 Cognitive battery Schizophrenia patients 20 200 mg p.o. qd for 8 weeks; double-blind, placebo-controlled No significant…”
BackgroundModafinil and Cocaine Interactions
Malcolm, R. J., Swayngim, K. D., Donovan, J. L., DeVane, C. L., Elkashef, A. M., Chiang, N., Khan, R., Mojsiak, J., Myrick, D. H., Hedden, S. L., et al. (2006) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990600920425 · Cited by 85
Randall, D. C., Fleck, N. L., Shneerson, J. M., & File, S. E. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.12.016 · Cited by 85 · cited 2×
“…2003 CANTAB cognitive Healthy adults; 45 0, 100, 200 mg p.o. parallel groups kRT Stroop color-naming, m accuracy Visual DMS, Spatial Planning, digit Randall et al, 2004 M o d a fin il n e u ro c h e m istry a n d c o g n itio n M J M inzenb erg and C S C arter 1 4 8 8 N euro p sycho p harm aco lo…”
BackgroundModafinil Attenuates Disruptions in Cognitive Performance During Simulated Night-Shift Work
Hart, C. L., Haney, M., Vosburg, S. K., Comer, S. D., Gunderson, E. G., & Foltin, R. W. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300991 · Cited by 83 · cited 2×
“…divided attention; m accuracy on immediate digit recall; m accuracy digit symbol; m sequence learning; m sustained attention (all at both doses) NA Hart et al, 2006 fMRI with N-back Sleep-deprived healthy adults 8 200 mg p.o. double-blind, placebocontrolled kRT on 2-Back only associated with…”
BackgroundThe hypocretin/orexin system in health and disease
Nishino, S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00349-4 · Cited by 82 · cited 1×
“The clinical efficacy of modafinil in narcolepsy, a condition characterized by a severe deficiency of orexin (hypocretin) in the brain (Nishino, 2003), suggests that modafinil may have clinically relevant effects on this neurochemical system.”
BackgroundTanganelli, S., Fuxé, K., Ferraro, L., Janson, A. M., & Bianchi, C. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00176625 · Cited by 82 · cited 5×
“Modafinil-induced reductions in GABA are abolished in the cortex by pre-treatment with 5HT2 receptor antagonists methysergide or ketanserin (Tanganelli et al, 1992), and in the hypothalamus by the 5HT3 antagonist MDL72222 (which alone has no effect on GABA levels) (Ferraro et al, 1996).”
BackgroundInfluentialWong, Y. N., King, S. P., Laughton, W. B., McCormick, G. C., & Grebow, P. E. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb04425.x · Cited by 79 · cited 2×
“Neuropsychopharmacology (2008) 33, 1477–1502; doi:10.1038/sj.npp.1301534; published online 22 August 2007 Keywords: modafinil; dopamine; norepinephrine; cognition; psychiatry”
BackgroundInfluentialArnsten, A. F. T., & Cai, J. X. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90044-c · Cited by 77 · cited 2×
“This phenomenon has also been demonstrated with yohimbine effects on spatial working memory in animal models (Arnsten and Cai, 1993).”
BackgroundModafinil in children with attention-deficit hyperactivity disorder
Rugino, T. A., & SAMSOCK, T. C. (2003) · Pediatric Neurology · doi:10.1016/s0887-8994(03)00148-6 · Cited by 77 · cited 3×
“…Flexible dose, 100–400 mg p.o. qd (mean 195 mg) for 2–7 weeks (mean 4.6) m TOVA ADHD score, including impulsivity and inattention subscores (improved) NA Rugino and Samsock, 2003 Test of variables of attention ADHD patients 200 Double-blind, flexible dose 85–425 mg p.o. qd (mean 361 mg) for…”
BackgroundMethodInfluentialSimon, P., Panissaud, C., & Costentin, J. (1994) · Psychopharmacology · doi:10.1007/bf02244990 · Cited by 77 · cited 4×
“No sleep rebound Sleep rebound: m deep SWS, paradoxical sleep Lin et al, 2000 Waking EEG Human 300 mg p.o. Amphetamine 20 mg p.o. Maintenance of a1 (8.5– 11.5 Hz) power after sleep deprivation Suppressed power in 0.5–7 Hz bands Chapotot et al, 2003 Locomotor activity Mouse 32–128 mg/kg i.p. Amphetamine 2–6 mg/kg i.p.…”
BackgroundInfluentialModafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors
Korotkova, T. M., Klyuch, B. P., Ponomarenko, A. A., Lin, J., Haas, H. L., & Sergeeva, O. A. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.09.005 · Cited by 75 · cited 3×
“…DA single units in rats (Akaoka et al, 1991), whereas a recent study found that in rat brain slices, modafinil (20 mM) inhibits the activity of ventral tegmental area DA neurons, with this effect abolished by sulpiride, blunted by nomifensine and unaffected by prazosin (Korotkova et al, 2006).”
BackgroundInfluentialEffect of modafinil and amphetamine on the rat catecholaminergic neuron activity
Akaoka, H., Roussel, B., Lin, J., Chouvet, G., & Jouvet, M. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90148-m · Cited by 75 · cited 6×
“Whereas modafinil does not affect the activity of NE single units in the locus coeruleus (LC) of anaesthetized rats (Akaoka et al, 1991), it remains unclear if this is an artifact of anesthesia (see discussion in Souliere et al, 2000).”
BackgroundMethodInfluentialBenefits of Adjunct Modafinil in an Open-Label, Pilot Study in Patients With Schizophrenia
Rosenthal, M. H., & Bryant, S. L. (2004) · Clinical Neuropharmacology · doi:10.1097/00002826-200401000-00011 · Cited by 74 · cited 3×
“Among studies of adult psychiatric patients using clinical outcome measures, adjunct modafinil has shown efficacy in a 4-week open-label study of 11 stable patients with chronic schizophrenia or schizoaffective disorder, with dosing at 100 or 200 mg/day (Rosenthal and Bryant, 2004).”
InfluentialChapotot, F., Pigeau, R., Canini, F., Bourdon, L., & Buguet, A. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1315-8 · Cited by 73 · cited 2×
“…EEG Human 300 mg p.o. Amphetamine 20 mg p.o. Maintenance of a1 (8.5– 11.5 Hz) power after sleep deprivation Suppressed power in 0.5–7 Hz bands Chapotot et al, 2003 Locomotor activity Mouse 32–128 mg/kg i.p. Amphetamine 2–6 mg/kg i.p. m Activity blocked by prazosin or reserpine, not by…”
BackgroundInfluentialRole of brain α1B‐adrenoceptors in modafinil‐induced behavioral activity
Stone, E. A., Cotecchia, S., Lin, Y., & Quartermain, D. (2002) · Synapse · doi:10.1002/syn.10127 · Cited by 72 · cited 5×
“…et al, 1994); its effect on activity shows stress-induced subsensitivity (which is prevented by corticosterone or dexamethasone pre-treatment) (Stone et al, 2002b); pre-treatment with the tyrosine hydroxylase inhibitor a-methyl-para-tyrosine has minimal effects on modafinil-induced increases…”
BackgroundInfluentialSchwartz, J. R. L., Nelson, M. T., Schwartz, E. R., & Hughes, R. J. (2004) · Clinical Neuropharmacology · doi:10.1097/00002826-200403000-00005 · Cited by 72 · cited 2×
“…Sangal et al, 1999b Wisconsin card sort test Narcolepsy patients 24 400 mg p.o. qd or 300 mg p.o. bid, vs placebo, for 3 weeks; double-blind k Errors NA Schwartz et al, 2004 P300 during visual or auditory oddball, PASAT Multiple sclerosis patients 33 100 mg p.o. qd for 4 weeks open-label NA No…”
BackgroundInfluentialDevoto, P., Flore, G., Vacca, G., Pira, L., Arca, A., Casu, M. A., Pani, L., & Gessa, G. L. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1381-y · Cited by 70 · cited 1×
“…the medial PFC (as well as occipital cortex) upon LC activation by either direct electrical stimulation or local infusion of a2 receptor antagonists, whereas both DA and NE are reduced in both cortical areas by local or systemic clonidine (Devoto et al, 2001, 2003, 2004a, b; Kawahara et al, 2001).”
BackgroundTourev, M., Sallanon, M. M., & Jouvet, M. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11448-6 · Cited by 70 · cited 2×
“No rebound m in paradoxical sleep Rebound m paradoxical sleep Touret et al, 1995 Wakefulness by EEG; locomotor activity Rat 30, 100, 300 mg/kg i.p. Methamphetamine 0.5, 1 mg/kg i.p.”
BackgroundInfluentialWaters, K. A., Burnham, K. E., O'Connor, D. V., Dawson, G. R., & Dias, R. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105048995 · Cited by 68 · cited 3×
“In contrast, a study where rats performed the 5- choice serial RT task, modafinil in general did not appear to have effects on attention measures, as well as measures of sensorimotor and inhibitory processes (Waters et al, 2005).”
BackgroundResultInfluentialFerraro, L., Fuxé, K., Tanganelli, S., Tomasini, M. C., Rambert, F. A., & Antonelli, T. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10196 · Cited by 67 · cited 1×
“Modafinil causes elevations in extracellular 5HT that are significant and dose-dependent in the frontal cortex, central nucleus of the amygdala, and dorsal raphe nucleus, but minimal in the hypothalamus (de Saint Hilaire et al, 2001; Ferraro et al, 2000, 2002).”
BackgroundDauvilliers, Y. A., Neidhart, E., Billiard, M. M., & Tafti, M. (2002) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500088 · Cited by 67 · cited 1×
“…attenuated by the D1 receptor antagonist SCH 23390 (Simon et al, 1995), although not by haloperidol (Duteil et al, 1990); and the low-activity catechol-O-methyl transferase genotype is associated with greater clinical response to modafinil among adults with narcolepsy (Dauvilliers et al, 2002).”
BackgroundModafinil and cortical γ-aminobutyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins
Tanganelli, S., de la Mora, M. P., Ferraro, L., Méndez-Franco, J., Beani, L., Rambert, F. A., & Fuxé, K. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00675-w · Cited by 66 · cited 7×
“…Gallopin et al, 2004 Extracellular GABA: no modafinil effect in cortex in prazosin pre-treated rats 30 mg/kg i.p. Intracranial microdialysis Rat Tanganelli et al, 1995 Effect on activity abolished in a1B-knockout mouse or by i.c.v. terazosin, not by i.c.v. BMY7378 (a1D) 20, 40 mg/kg i.p.…”
BackgroundInfluentialModafinil improves attention, inhibitory control, and reaction time in healthy, middle-aged rats.
Morgan, R. E., Crowley, J., Smith, R. H., LaRoche, R. B., & Dopheide, M. M. (2007) · Pharmacology, Biochemistry and Behavior · doi:10.1016/j.pbb.2007.01.015 · Cited by 66 · cited 2×
“Another study tested the effects on visual discrimination and visual sustained attention of oral doses of modafinil, from 8 to 64 mg/kg, administered to middle-aged female rats (Morgan et al, 2007).”
BackgroundUse of modafinil in the treatment of narcolepsy: A long term follow-up study
Besset, A., Chetrit, M., Carlander, B., & Billiard, M. M. (1996) · Neurophysiologie Clinique · doi:10.1016/0987-7053(96)81535-8 · Cited by 64
Is Psychosis Exacerbated by Modafinil?
Narendran, R., Young, C. M., Valenti, A. M., Nickolova, M. K., & Pristach, C. A. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.3.292 · Cited by 64
Meunier, M., Jaffard, R., & Destrade, C. (1991) · Behavioural Brain Research · doi:10.1016/s0166-4328(05)80018-x · Cited by 63 · cited 1×
“…to use current cues to rapidly adopt a context-appropriate strategy to make correct responses, and this learning curve is sensitive to damage to either the anterior cingulate (but not posterior cingulate) cortex or the mediodorsal nucleus of the thalamus (Krazem et al, 1995; Meunier et al, 1991).”
BackgroundKawahara, H., Kawahara, Y., & Westerink, B. H. C. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00863-9 · Cited by 63 · cited 1×
“…the medial PFC (as well as occipital cortex) upon LC activation by either direct electrical stimulation or local infusion of a2 receptor antagonists, whereas both DA and NE are reduced in both cortical areas by local or systemic clonidine (Devoto et al, 2001, 2003, 2004a, b; Kawahara et al, 2001).”
BackgroundThase, M. E., Fava, M., DeBattista, C., Arora, S., & Hughes, R. J. (2006) · CNS Spectrums · doi:10.1017/s1092852900010622 · Cited by 63
Potency of catecholamines and other l-tyrosine derivatives at the cloned mouse adrenergic receptors
Zhang, W., Ouyang, M., & THOMAS, S. A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.04.017 · Cited by 62 · cited 1×
“DA has an affinity for cloned mouse a1B receptors, which is on the same order of magnitude as NE (Zhang et al, 2004), and DA can activate adrenergic receptors in various brain regions (Cornil et al, 2002; Crochet and Sakai, 2003; Malenka and Nicoll, 1986).”
BackgroundFirst evidence of a delay-dependent working memory-enhancing effect of modafinil in mice
Béracochéa, D., Cagnard, B., Célérier, A., Merrer, J. L., Pérès, M., & Piérard, C. (2001) · NeuroReport · doi:10.1097/00001756-200102120-00038 · Cited by 61 · cited 3×
“MJ Minzenberg and CS Carter 1487 Neuropsychopharmacology Table 3 Effects of Modafinil on Cognition and Other Information-Processing Measures Measure Subject sample N Dose/route/design Positive effects on performance Lack of effect Reference Delayed spontaneous alternation (SA) Mouse 8/grp 8, 32, 64 mg/kg i.p. m Altern…”
BackgroundEllis, C., Monk, C., Simmons, A., Lemmens, G. M. D., Williams, S., Brammer, M. J., Bullmore, E. T., & Parkes, J. D. (1999) · Journal of Sleep Research · doi:10.1046/j.1365-2869.1999.00142.x · Cited by 60
Effects of modafinil on cognitive performance and alertness during sleep deprivation.
Wesensten, N. (2006) · Current pharmaceutical design · doi:10.2174/138161206777698819 · Cited by 59 · cited 1×
“Several studies of modafinil effects on cognition in healthy adults undergoing sleep deprivation or simulated night shifts have been reported (see (Wesensten, 2006) for review).”
BackgroundBiederman, J., Swanson, J. M., Wigal, S. B., Boellner, S. W., Earl, C. Q., López, F. A., & Modafinil ADHD Study Group (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0506 · Cited by 58
Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers
Robertson, P., Hellriegel, E., Arora, S., & Nelson, M. T. (2002) · Clinical pharmacology and therapy · doi:10.1067/mcp.2002.121217 · Cited by 57 · cited 2×
“…have found significant interactions of modafinil with ethinylestradiol and triazolam (through CYP3A4 induction in the gastrointestinal system) (Robertson et al, 2002b), although not with methylphenidate (Hellriegel et al, 2001; Wong et al, 1998a), dextroamphetamine (Hellriegel et al, 2002;…”
BackgroundWong, Y. N., Wang, L., Hartman, L. M., Simcoe, D. K., Chen, Y., Laughton, W. B., Eldon, R., Markland, C., & Grebow, P. E. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb04395.x · Cited by 56 · cited 1×
“Neuropsychopharmacology (2008) 33, 1477–1502; doi:10.1038/sj.npp.1301534; published online 22 August 2007 Keywords: modafinil; dopamine; norepinephrine; cognition; psychiatry”
InfluentialFuxé, K., Janson, A. M., Rosén, L., Finnman, U.-B., Tanganelli, S., Morari, M., Goldstein, M., & Agnati, L. F. (1992) · Experimental Brain Research · doi:10.1007/bf02259133 · Cited by 56 · cited 2×
“…loss of DA or non-DA neurons in SN after MPTP 100 mg/kg i.p. Tyr-Hydroxylase-IR C57bl/6 mouse Aguirre et al, 1999 Prevents loss of DA neurons in SN, DAT in striatum, or DA in SN/striatum, after MPTP 10–100 mg/kg i.p. for 2 weeks TH-IR; intracranial microdialysis black mouse Fuxe et al, 1992”
BackgroundA Randomized, Double-Blind, Crossover Trial of Modafinil on Mood
Taneja, I., Haman, K., Shelton, R. C., & Robertson, D. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31802eb7ea · Cited by 55
Sawaguchi, T. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.4.2200 · Cited by 55 · cited 1×
“The role of post-synaptic a2 receptor-mediated transient increases in PFC delay-related activity (Li et al, 1999; Sawaguchi, 1998), and associated mitigation of interference in task performance (Arnsten and Contant, 1992), suggest a point of convergence of the Arnsten model of adrenergic function with the Aston-Jones…”
MethodModafinil and unconstrained motor activity in schizophrenia
Farrow, T. F. D., Hunter, M. D., Haque, R., & Spence, S. A. (2006) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.105.017335 · Cited by 54
Lin, J., Gervasoni, D., Hou, Y., Vanni-Mercier, G., Rambert, F. A., Frydman, A. M., & Jouvet, M. (2000) · Journal of Sleep Research · doi:10.1046/j.1365-2869.2000.00181.x · Cited by 54 · cited 2×
“…et al, 1996); it does not produce behavioral stereotypies (Duteil et al, 1990; Simon et al, 1995) or rebound hypersomnia (Edgar and Seidel, 1997; Lin et al, 2000; Touret et al, 1995; Willie et al, 2005; Wisor et al, 2006); it does not significantly alter behavior in the elevated-plus maze…”
BackgroundInfluentialNishino, S., Fruhstorfer, B., Arrigoni, J., Guilleminault, C., Dement, W. C., & Mignot, E. J.-M. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10116-x · Cited by 53 · cited 1×
“However, modafinil lacks the capacity to reduce cataplexy in dogs or humans with narcolepsy (Billiard et al, 1994; Shelton et al, 1995), a feature which is similar to other DAT inhibitors, and in contrast to a1B agonists and NET inhibitors (Mignot et al, 1993; Nishino et al, 1993).”
ResultSamuels, E. R., Hou, R. H., Langley, R. W., Szabadi, E., & Bradshaw, C. M. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106060770 · Cited by 52 · cited 1×
“In a study of healthy adults, single-dose modafinil 200 mg caused a reduction in blood prolactin levels; however, unlike the D2/D3 agonist pramipexole, it had no effect on blood growth hormone or thyroid stimulating hormone in these subjects (Samuels et al, 2006).”
BackgroundModafinil Activates Cortical and Subcortical Sites in the Sleep-Deprived State
THOMAS, R. J., & Kwong, K. K. (2006) · SLEEP · doi:10.1093/sleep/29.11.1471 · Cited by 50 · cited 4×
“…adults 8 200 mg p.o. double-blind, placebocontrolled kRT on 2-Back only associated with extensive cortical activation RT on 1-Back and 3-Back Thomas and Kwong, 2006 Flight simulator Sleep-deprived healthy adults 200 mg p.o. within-subject counterbalanced Attenuated decline in performance…”
MethodInfluentialDagan, Y., & Doljansky, J. T. (2006) · Chronobiology International · doi:10.1080/07420520600920734 · Cited by 48
de Séréville, J.-E., Boer, C., Rambert, F. A., & Duteil, J. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90115-5 · Cited by 48 · cited 2×
“…affect the spontaneous release of DA from mouse striatal synaptosomes (Simon et al, 1995) or turnover of DA in the mouse caudate nucleus in vivo (De Sereville et al, 1994); it shows negligible effects on cerebral cortical blood flow (Florence et al, 2000), and different patterns of metabolic…”
BackgroundImprovement of learning processes following chronic systemic administration of modafinil in mice.
Béracochéa, D., Célérier, A., Borde, N., Valleau, M., Pérès, M., & Piérard, C. (2002) · Pharmacology, Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00877-8 · Cited by 48 · cited 2×
“…rule (learning rate) at 64 mg/kg (not at 32 mg/kg) Day 1 Acquisition rate; forgetting rates; contingently reinforced alternation rates over 5 d Beracochea et al, 2002 Serial spatial discrimination reversal Mouse 10/grp 32, 64 mg/kg i.p. qd for 5 d Faster emergence of win-stay rule (learning…”
BackgroundEnhancement of learning processes following an acute modafinil injection in mice.
Béracochéa, D., Célérier, A., Pérès, M., & Piérard, C. (2003) · Pharmacology, Biochemistry and Behavior · doi:10.1016/j.pbb.2003.09.007 · Cited by 48 · cited 2×
“It also dosedependently improves performance of mice on a serial reversal discrimination task (Beracochea et al, 2003).”
BackgroundPiérard, C., Liscia, P., Valleau, M., Drouet, I., Chauveau, F., Huart, B., Bonneau, D., Jouanin, J.-C., Beaumont, M., & Béracochéa, D. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.11.018 · Cited by 47 · cited 2×
“Modafinil also dose-dependently improves the rate of spontaneous alternation as a measure of working memory performance in mice (Pierard et al, 2006).”
BackgroundMethodSaletu, M., Anderer, P., Saletu-Zyhlarz, G. M., Mandl, M., Arnold, O., Zeitlhofer, J., & Saletu, B. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0543-8 · Cited by 46
Inhibitory effects of trace amines on rat midbrain dopaminergic neurons
Geracitano, R., Federici, M., Prisco, S., Bernardi, G., & Mercuri, N. B. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.11.031 · Cited by 46 · cited 2×
“There is recent evidence for modulatory interactions between the TA1 receptor and both DA neuron activity in rats (Geracitano et al, 2004) and DAT activity in primates (Miller et al, 2005; Xie and Miller, 2007; Xie et al, Modafinil neurochemistry and cognition MJ Minzenberg and CS…”
BackgroundInfluentialFerraro, L., Fuxé, K., Agnati, L. F., Tanganelli, S., Tomasini, M. C., & Antonelli, T. (2005) · Synapse · doi:10.1002/syn.20111 · Cited by 45 · cited 1×
“In addition, modafinil and the 5HT reuptake inhibitors fluoxetine, paroxetine, and imipramine mutually enhance the effect of each other on elevations in cortical 5HT (Ferraro et al, 2000, 2005).”
BackgroundModafinil facilitates performance on a delayed nonmatching to position swim task in rats
Ward, C. P., Harsh, J., York, K. M., Stewart, K. L., & McCoy, J. G. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.05.005 · Cited by 45 · cited 2×
“%) qd Performance at 30 mg/kg Ward et al, 2004 Cognitive battery Rat 0, 8, 32, 64 mg/kg i.p. m Accuracy, kRT and k premature responses on 3-choice visual attention task with long delay at 64 mg/kg only Visual discrimination performance; omission errors or measures of motivation or motor activity…”
BackgroundA possible α-adrenergic mechanism for drug (CRL 40028)-induced hyperactivity
Duteil, J., Rambert, F. A., Pessonnier, J., Gombert, R., & Assous, E. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90033-5 · Cited by 43 · cited 1×
“In addition, pre-treatment with low doses of the a2 antagonist yohimbine potentiates modafinil-induced wakefulness (Lin et al, 1992) and activity (Duteil et al, 1990), whereas higher doses attenuate the activity increases (Duteil et al, 1979).”
BackgroundEffects of modafinil-induced wakefulness on glutamine synthetase regulation in the rat brain
Touret, M., Sallanon, M. M., Fages, C., Roudier, V., Didier‐Bazès, M., Roussel, B., Tardy, M., & Jouvet, M. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90082-5 · Cited by 43 · cited 2×
“This increase in the glutamate–glutamine pool may result from increased glutamine synthetase activity, as the mRNA content of this enzyme is increased after modafinil (Touret et al, 1994).”
BackgroundCrochet, S., & Sakai, K. (2003) · SLEEP · doi:10.1093/sleep/26.7.801 · Cited by 43 · cited 2×
“DA has an affinity for cloned mouse a1B receptors, which is on the same order of magnitude as NE (Zhang et al, 2004), and DA can activate adrenergic receptors in various brain regions (Cornil et al, 2002; Crochet and Sakai, 2003; Malenka and Nicoll, 1986).”
BackgroundMania in a Boy Treated With Modafinil for Narcolepsy
Vorspan, F., Warot, D., Consoli, A., Cohen, D., & Mazet, P. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.813-a · Cited by 40
Aston‐Jones, G., Rajkowski, J., Ivanova, S. А., Usher, M., & Cohen, J. D. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60857-1 · Cited by 39
Wisor, J. P., Dement, W. C., Aimone, L. D., WILLIAMS, M., & Bozyczko‐Coyne, D. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.09.018 · Cited by 36 · cited 3×
“…not assoc with m activity; no acute rebound hypersomnolence m waking and m activity at similar AMP doses; + acute rebound hypersomnolence (m NREMS) Wisor et al, 2006 Wakefulness by EEG Cat 1 mg/kg p.o. Amphetamine 0.25 mg./kg p.o. m Waking blocked by phentolamine, prazosin, or propranolol, but…”
BackgroundInfluentialEffects of a vigilance-enhancing drug, modafinil, on rat brain metabolism: 2D COSY 1H-NMR study
Piérard, C., Satabin, P., Lagarde, D., Barrère, B., Guezennec, C. Y., Menu, J.-P., & Pérès, M. (1995) · Brain Research · doi:10.1016/0006-8993(95)00711-x · Cited by 34 · cited 2×
“However, there is evidence that modafinil causes increases in the cerebral glutamate–glutamine pool (along with elevations in aspartate and creatine–phosphocreatine, although not in N-acetyl aspartate or taurine), as measured by 2D COSY 1H-NMR (Pierard et al, 1995).”
BackgroundSaletu, M., Anderer, P., Semlitsch, H. V., Saletu-Zyhlarz, G. M., Mandl, M., Zeitlhofer, J., & Saletu, B. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.04.005 · Cited by 34 · cited 1×
“…r¼ 0.45 ACC), theta (peak r¼ 0.65 medFG), slow alpha (peak r¼ 0.55 in medFG) by EEG-LORETA, esp left frontal cortex Visual/auditory divided attention RT Saletu et al, 2007 M o d a fin il n e u ro c h e m istry a n d c o g n itio n M J M inzenb erg and C S C arter 1 4 8 9 N euro p sycho p harm aco…”
InfluentialSchwertner, H. A., & Kong, S. B. (2004) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2004.11.014 · Cited by 31 · cited 2×
“Modafinil can be reliably determined in plasma and urine (Schwertner and Kong, 2005; Tseng et al, 2005), and is readily absorbed (40–65%, as measured by urinary recovery) after single (Wong et al, 1999a) or multiple oral doses (Wong et al, 1999b), reaching peak plasma concentrations 2–4 h after administration (Wong et…”
BackgroundAguirre, J. A., Cintra, A., Hillion, J., Narváez, J. Á., Jansson, A., Antonelli, T., Ferraro, L., Rambert, F. A., & Fuxé, K. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00706-5 · Cited by 30 · cited 2×
“…microdialysis Guinea pig Tanganelli et al, 1994 Prevents loss of DA or non-DA neurons in SN after MPTP 100 mg/kg i.p. Tyr-Hydroxylase-IR C57bl/6 mouse Aguirre et al, 1999 Prevents loss of DA neurons in SN, DAT in striatum, or DA in SN/striatum, after MPTP 10–100 mg/kg i.p. for 2 weeks TH-IR;…”
Backgroundde la Mora, M. P., Aguilar-Garcı́a, A., Ramón-Frías, T., Ramı́rez-Ramı́rez, R., Méndez-Franco, J., Rambert, F. A., & Fuxé, K. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00905-7 · Cited by 30 · cited 4×
“…i.p. Intracranial microdialysis Rat Ferraro et al, 1997b No inhibition of GABA neurons in VTA/SN 20 mM Extracellular recording Rat brain slices Korotkova et al, 2006 No effects on synthesis of hypothalamic GABA 100 mg/kg i.p. [3H] GABA synthesis Rat brain synaptosomes Perez de la Mora et al, 1999”
BackgroundInfluentialModafinil prevents glutamate cytotoxicity in cultured cortical neurons
Antonelli, T., Ferraro, L., Hillion, J., Tomasini, M. C., Rambert, F. A., & Fuxé, K. (1998) · Neuroreport · doi:10.1097/00001756-199812210-00038 · Cited by 30 · cited 3×
“Interestingly, modafinil does prevent the effect of glutamate cytotoxicity on reduction of GABA release from cultured cortical neurons (Antonelli et al, 1998).”
BackgroundInfluentialRobertson, P., Hellriegel, E. T., Arora, S., & Nelson, M. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/00912700222011120 · Cited by 29 · cited 2×
“…have found significant interactions of modafinil with ethinylestradiol and triazolam (through CYP3A4 induction in the gastrointestinal system) (Robertson et al, 2002b), although not with methylphenidate (Hellriegel et al, 2001; Wong et al, 1998a), dextroamphetamine (Hellriegel et al, 2002;…”
BackgroundModafinil-Associated Clozapine Toxicity
DeQuardo, J. R. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1243-a · Cited by 28 · cited 1×
“Whereas other single case reports have appeared describing adverse events in the treatment of psychiatric patients such as clozapine toxicity (Dequardo, 2002), premature ventricular contractions (Oskooilar, 2005), induced mania (Vorspan et al, 2005; Wolf et al, 2006), and irritability and verbal aggression (Ranjan and…”
ResultSouli�re, F., Urbain, N., Gervasoni, D., Schmitt, P., Guillemort, C., Fort, P., Renaud, B., Luppi, P., & Chouvet, G. (2000) · Journal of Neuroscience Research · Cited by 28
Wieland, H., Söll, R., Doods, H. N., Stenkamp, D., Hurnaus, R., Lämmle, B., & Beck‐Sickinger, A. G. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02739.x · Cited by 27 · cited 2×
“…Rat Scammell et al, 2000 No binding to orexin-1 receptor IC50 410mM 125I-human-orexin B displacement Transfected Chinese Hamster Ovary cells Wieland et al, 2002 No change in Fos-IR, and m effect of modafinil on waking EEG, in orexin-null mice 10, 100 mg/kg i.p. Immunohisto-chemistry; EEG,…”
BackgroundManic Switch in a Patient With Treatment-Resistant Bipolar Depression Treated With Modafinil
Wolf, J., Fiedler, U., Anghelescu, I. G., & Schwertfeger, N. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1122a · Cited by 27
P300 and treatment effect of modafinil on fatigue in multiple sclerosis
Nagels, G., D'hooghe, M. B., Vleugels, L., Kos, D., Despontin, M., & Deyn, P. P. D. (2006) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2005.10.008 · Cited by 27 · cited 1×
“…oddball, PASAT Multiple sclerosis patients 33 100 mg p.o. qd for 4 weeks open-label NA No correlation between clinical response and P300 or PASAT score Nagels et al, 2007 CANTAB battery, digit span and stop task Schizophrenia patients 20 200 mg p.o. m Accuracy Digit Span (forward and backward),…”
Method
Research works printed but not linked: 1
- Wong YN, Simcoe D, Hartman LN, Laughton WB, King SP, McCormick GC et al (1999b). A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J Clin Pharmacol 39: 30–40. · DOI · Paper page
Cited by
Inhibition and impulsivity: behavioral and neural basis of response control
Bari, A., & Robbins, T. W. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.005 · Cited by 1,921
Towards responsible use of cognitive-enhancing drugs by the healthy
Greely, H., Sahakian, B., Harris, J., Kessler, R. C., Gazzaniga, M., Campbell, P., & Farah, M. J. (2008) · Nature · doi:10.1038/456702a · Cited by 862
del Campo, N., Chamberlain, S. R., Sahakian, B. J., & Robbins, T. W. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.036 · Cited by 685
Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review
Repantis, D., Schlattmann, P., Laisney, O., & Heuser, I. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.04.002 · Cited by 576
Eagle, D. M., Bari, A., & Robbins, T. W. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1127-6 · Cited by 548
Metadata
- Authors
- Minzenberg, M. J., & Carter, C. S.
- Affiliations
- University of California Davis Medical Center (US)
- Corresponding author
- Minzenberg, Michael J
- Venue
- Neuropsychopharmacology
- Published
- 2007-08-22
- Volume
- 33
- Issue
- 7
- Pages
- 1477-1502
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2122011624
- Semantic Scholar
- cf5b2a15296e7832bcfdd965f28583772ef2999c
- Cited by
- 713
- References
- 215
- Citations by year
- 2026: 18 · 2025: 32 · 2024: 25 · 2023: 33 · 2022: 33 · 2021: 46 · 2020: 26 · 2019: 19 · 2018: 33 · 2017: 42 · 2016: 22 · 2015: 49 · 2014: 48 · 2013: 62 · 2012: 59
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH 59883, MH066629, R01MH059883, R01MH066629)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Arts and Humanities › Philosophy › Neuroethics, Human Enhancement, Biomedical Innovations
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Keywords
- modafinil, wakefulness-promoting agents, neurochemical mechanisms, cognition, catecholamines, serotonin, glutamate, GABA, orexin, histamine, working memory, episodic memory, prefrontal cortex, cognitive control, treatment-resistant depression, attention deficit hyperactivity disorder, schizophrenia, cognitive impairment, pharmacokinetics, abuse liability
- MeSH terms
- Modafinil, Animals, Mental Disorders, Benzhydryl Compounds, Brain Chemistry, Cognition, Humans, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.